Chang Gao, Ya-Nan Peng, Hai-Zhou Wang, Shi-Lin Fang, Meng Zhang, Qiu Zhao and Jing Liu* Pages 849 - 855 ( 7 )
Heat shock protein 90 (Hsp90) plays an essential role in various physiological and pathological processes. It activates client proteins to participate in tumor progression. Blocking Hsp90 could enable effective antitumor effects in many tumor types, such as multiple myeloma and colon cancer. Recently, it has motivated an interest in Hsp90 inhibitors that bind to the N-terminal or C-terminal ATP pocket as antitumor drugs. We reviewed the data from experimental and clinical trials on Hsp90 inhibitors in the treatment of different malignancies to explore and summarize their antitumor mechanisms.
Heat shock protein 90, signaling pathway, client protein, ATPase, inhibitor, cancer treatment.
Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan